Impairment of cardiac beta-adrenoceptor cellular signaling by decreased expression of G(s alpha) in septic rabbits.
BACKGROUND
Abnormalities in the beta-adrenergic control of cardiac function play a role in the pathogenesis of several disease states. Because circulatory failure in patients with septic shock is known to be less responsive to catecholamines, we investigated whether the beta-adrenoceptor-linked signal transduction mechanisms are altered in the heart of a septic animal model


METHODS
Rabbits were rendered endotoxemic by an intravenous injection of 100 microg/kg Escherichia coli lipopolysaccharide. Three and 6 h later, the myocardial tissues were used for the experiments.


RESULTS
The positive inotropic response to isoproterenol was significantly impaired in papillary muscles isolated from septic rabbits compared with those from controls. The impaired inotropic responsiveness to isoproterenol was not prevented by the nitric oxide synthase inhibitor N(G)-nitro-L-arginine, indicating no involvement of nitric oxide overproduction. Adenylate cyclase activity stimulated with isoproterenol and 5'-guanylyl imidodiphosphate was markedly reduced in septic myocardium. The contractile and adenylate cyclase responses to colforsin daropate, a direct adenylate cyclase activator, were unaffected by sepsis. Radioligand binding experiments with (-)[125I]iodocyanopindolol revealed no significant alteration in myocardial beta-adrenoceptor density or affinity in sepsis. Determination of cardiac G(s alpha) level by Western blotting showed a reduction of approximately 50% in sepsis. The relative content of G(s alpha) messenger RNA in septic myocardium also was reduced from the control level by about 50%, as determined by Northern blot analysis. Little change was found in protein and messenger RNA levels of G(s alpha) in septic myocardium.


CONCLUSIONS
Impairment of myocardial functional responsiveness to beta-adrenoceptor stimulation appears in the early stage of sepsis. The impaired response to beta-adrenoceptor stimulation in the heart in this pathologic state may result in part from a decreased level of G(s alpha) protein which occurs at the level of gene expression.
Matsuda
N
N
Hokkaido University School of Medicine, Sapporo, Japan.
Hattori
Y
Y
Akaishi
Y
Y
Suzuki
Y
Y
Kemmotsu
O
O
Gando
S
S
D000262:Adenylyl Cyclases / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000378:metabolism; D000818:Animals; D001794:Blood Pressure / Q000502:physiology*; D004926:Escherichia coli; D019204:GTP-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation; D006339:Heart Rate / Q000502:physiology*; D020120:Iodocyanopindolol / Q000378:metabolism; D008070:Lipopolysaccharides; D023421:Models, Animal; D009200:Myocardial Contraction / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D012772:Shock, Septic / Q000503:physiopathology*; D015398:Signal Transduction / Q000502:physiology*
D000319:Adrenergic beta-Antagonists; D008070:Lipopolysaccharides; D012333:RNA, Messenger; D011943:Receptors, Adrenergic, beta; D020120:Iodocyanopindolol; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases